Treatment with the recombinant SLIT2 protein delays AML leukemogenesis in vivo (2021)
- Authors:
- USP affiliated authors: REGO, EDUARDO MAGALHÃES - FM ; SIMÕES, LUÍSE ARAÚJO DE ALBUQUERQUE - FM ; WEINHÄUSER, ISABEL - FMRP ; MARTINS, DIEGO ANTONIO PEREIRA - FMRP ; ROJAS, CÉSAR ALEXANDER ORTIZ - FMRP ; BIANCO, THIAGO MANTELLO - FMRP
- Unidades: FM; FMRP
- DOI: 10.1182/blood-2021-151069
- Subjects: PROTEÍNAS; LEUCEMIA
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2021
- Source:
- Conference titles: ASH Annual Meeting
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
SIMÕES, Luíse Araújo de Albuquerque et al. Treatment with the recombinant SLIT2 protein delays AML leukemogenesis in vivo. Blood. Washington: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-151069. Acesso em: 27 dez. 2025. , 2021 -
APA
Simões, L. A. de A., Weinhäuser, I., Martins, D. A. P., Rojas, C. A. O., Bianco, T. M., Cavaglieri, R. de C., & Rego, E. M. (2021). Treatment with the recombinant SLIT2 protein delays AML leukemogenesis in vivo. Blood. Washington: Faculdade de Medicina, Universidade de São Paulo. doi:10.1182/blood-2021-151069 -
NLM
Simões LA de A, Weinhäuser I, Martins DAP, Rojas CAO, Bianco TM, Cavaglieri R de C, Rego EM. Treatment with the recombinant SLIT2 protein delays AML leukemogenesis in vivo [Internet]. Blood. 2021 ; 138 2368.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1182/blood-2021-151069 -
Vancouver
Simões LA de A, Weinhäuser I, Martins DAP, Rojas CAO, Bianco TM, Cavaglieri R de C, Rego EM. Treatment with the recombinant SLIT2 protein delays AML leukemogenesis in vivo [Internet]. Blood. 2021 ; 138 2368.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1182/blood-2021-151069 - Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic leukemia
- Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia
- MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model
- M2 macrophages drive resistance to phagocytosis and improve mitochondrial metabolism in acute myeloid leukemia facilitating leukemic transformation and in vivo engraftment
- Tumor associated macrophages promoted fatal patient derived acute promyelocytic leukemia in vivo
- Alpha thalassemia, but not βS-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort
- Clinical Signicance of Mitochondrial DNA Content in Acute Promyelocytic Leukemi
- Association of HMIP1 C-893A polymorphism and disease severity in patients with sickle cell anemia
- Quantification of TP73 gene transcripts in acute promyelocytic leukemia and its impact on prognosis and treatment response
- Regulação das células-tronco hematopoéticas mediada pelas células Natural Killer em modelo de neoplasia mieloproliferativa
Informações sobre o DOI: 10.1182/blood-2021-151069 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003237416.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
